跳至主要内容
临床试验/PACTR202106917652038
PACTR202106917652038尚未招募未知

ebulized furosemide as adjunctive therapy in patients with stable chronic obstructive pulmonary disease : A randomized controlled trial

Medical Research Institute Alexandria University0 个研究点目标入组 100 人开始时间: 2021年6月4日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
45 Year(s) 至 64 Year(s)(—)
性别
All

入选标准

  • Stable (Not exacerbating) COPD patients documented by the pulmonologist
  • - FEV1, FVC, (FEV1/FVC) less than 70%
  • - Irreversible response to inhaled ß-agonist (FEV1i ncrease <12% and <200 cc after15min from baseline)
  • - Symptoms last about 5 years of breathlessness and, productive cough

排除标准

  • Patients with history of other lung diseases such as pneumonia, idiopathic pulmonary fibrosis, consolidation, congestive heart failure, exacerbated, asthma or asthma-COPD overlap.
  • Smoking more than 15 packs/year
  • using furosemide and other diuretics

研究者

发起方
Medical Research Institute Alexandria University

相似试验